Journal List > Infect Chemother > v.45(4) > 1035279

Jeong, Ann, Kim, Choi, Kim, Han, Choi, Peck, Kang, Yeom, Choi, Lim, Song, Choi, Yoon, Kim, Kim, Kim, Park, and Kim: Incidence and Risk Factors for Surgical Site Infection after Gastric Surgery: A Multicenter Prospective Cohort Study

Abstract

Background

Surgical site infection (SSI) is a potentially morbid and costly complication of surgery. While gastrointestinal surgery is relatively common in Korea, few studies have evaluated SSI in the context of gastric surgery. Thus, we performed a prospective cohort study to determine the incidence and risk factors of SSI in Korean patients undergoing gastric surgery.

Materials and Methods

A prospective cohort study of 2,091 patients who underwent gastric surgery was performed in 10 hospitals with more than 500 beds (nine tertiary hospitals and one secondary hospital). Patients were recruited from an SSI surveillance program between June 1, 2010, and August 31, 2011 and followed up for 1 month after the operation. The criteria used to define SSI and a patient's risk index category were established according to the Centers for Disease Control and Prevention and the National Nosocomial Infection Surveillance System. We collected demographic data and potential perioperative risk factors including type and duration of the operation and physical status score in patients who developed SSIs based on a previous study protocol.

Results

A total of 71 SSIs (3.3%) were identified, with hospital rates varying from 0.0 - 15.7%. The results of multivariate analyses indicated that prolonged operation time (P = 0.002), use of a razor for preoperative hair removal (P = 0.010), and absence of laminar flow in the operating room (P = 0.024) were independent risk factors for SSI after gastric surgery.

Conclusions

Longer operation times, razor use, and absence of laminar flow in operating rooms were independently associated with significant increased SSI risk after gastric surgery.

Introduction

Surgical site infection (SSI) is the most common type of healthcare-associated infection in patients undergoing surgery and remains a major source of postoperative morbidity [1] Among surgical patients, SSIs account for 38% of healthcare-associated infections [2]. Of 16 million patients undergoing surgical procedures in the United States each year, it is estimated 2 to 5% developed SSIs [3, 4]. SSIs can lead to prolonged hospitalization, increased morbidity and mortality, and increased surgery-related costs [5, 6]. Therefore, to reduce SSIs, it is important to clarify risk factors.
The National Nosocomial Infection Surveillance (NNIS) risk indices for SSIs comprise three crucial measures, namely, the American Society of Anesthesiologists (ASA) classification, wound classification, and operation duration [7-9]. SSI rates correlate with the magnitude of the risk index in 77% (34/44) of NNIS procedure categories [8]. In Korea, the incidence of SSI ranges from 2.0% to 9.7% based on previous studies of various surgical procedures including gastrointestinal, hepatobiliary, orthopedic, gynecologic, and cardiac surgery [10-13].
Risk factors for SSIs have been well studied in various types of gastrointestinal surgery, particularly colorectal surgery [14-16]; however, little information is currently available on risk factors for SSIs after gastrectomy. Gastrointestinal surgery is relatively common in Korea, especially for treatment of gastric cancer. Indeed, according to the 2007 National Survey in Korea, gastric cancer incidence rate in men and women reached 62.8 and 25.7 cases per 100,000 people, respectively [17]. For these reasons, we investigated the incidence rate and characteristics of SSI after gastric surgery.

Materials and Methods

1. Patients and study design

Data were obtained from 10 hospitals in various regions around Korea. Each participating hospital comprised more than 500 beds, and nine were university-affiliated teaching hospitals. All patients who underwent gastric surgery from June 1, 2010 to August 31, 2011 at the Korean hospitals evaluated in this study were prospectively enrolled. Patients with the following criteria were excluded from the evaluation cohort: (1) preoperative identification of infectious disease; (2) febrile status within 24 hours prior to surgery; (3) an ASA score ≥ 4; (4) transfer to another hospital during the follow-up period for which data were not collected; (5) emergent surgery; (6) surgery for trauma; (7) more than two surgeries during the same hospital stay; and (8) multiple surgical sites during the same operation.

2. Data collection

The duration of the follow-up period used to identify SSIs was the first 30 days post-operation. Data were collected for the surgical procedure performed and potential SSI risk factors. Data from patients who developed SSIs were collected as previously described [7, 18-21], and these data included demographic characteristics, dates of admission and discharge, presence of anemia (hemoglobin level < 10 mg/dL) during preoperative evaluation, steroid use (at least 6 weeks) within 6 months of surgery, use of immunosuppressive drugs other than steroids within one month of surgery, history of chemotherapy within one month of surgery, current use of antacid medication within one week of surgery, hemoglobin A1c levels for 3 months prior to surgery, operation characteristics (i.e., type, date, and duration of the surgical procedure, ASA physical status score [22], and any use of endoscopic surgical approach), total amount of blood loss during the operation, preoperative hair removal methods, perioperative antimicrobial prophylaxis, presence of drains, occurrence of SSI, the environment of operating rooms, and microbiological data for any SSIs that developed.

3. Definitions

The criteria used to define SSIs and a patient's risk index category were established according to the guidelines of the CDC and NNIS [2, 4, 7, 23, 24]. The NNIS risk index score for each patient was calculated by assigning one point for each contaminated wound according to the CDC definition [25], an ASA score ≥ 3, and surgical procedures lasting longer than the NNIS-derived 75th percentile for procedure duration (T time). The NNIS score was modified by subtracting 1 point for cases where the surgery was performed by a laparoscopic approach as suggested by Gaynes et al.[8]. A SSI group was defined as patients who underwent gastric surgery during the study period at any of the participating hospitals and who acquired an SSI according to the CDC criteria.
Antimicrobial prophylaxis was considered optimal if a first- or second-generation cephalosporin was administered intravenously within the 60 min period preceding incision in the absence of a β-lactam allergy, and if prophylactic antimicrobials were discontinued within 24 h after the surgery was completed [26].

4. Statistical analysis

All factors were compared between the SSI group and non-SSI group using Student's t-test or Chi-square test. Relationships between dichotomous variables were assessed using Pearson's Chi-square test. Multivariate analysis was also performed using a logistic regression model and stepwise regression to assess the effects of various factors on SSIs. All statistical tests were performed using SPSS software for Windows, version 18.0 (SPSS Inc., Chicago, IL, USA). All P-values were two-tailed, and values less than 0.05 were considered statistically significant.

Results

From June 2010 to August 2011, a total of 2,091 patients who underwent gastric surgery were included in the study. SSIs were noted in 71 of 2,091 (3.3%) patients following gastric surgery, with varying from 0.0% to 15.7% according to each hospital. The clinical characteristics and preoperative status of study participants are summarized in Table 1. There were no significant differences in age and gender between the SSI and non-SSI groups (P = 0.290 and 0.312, respectively). Univariate analysis did not find an association between underlying diseases and SSI development in the two groups. Patients with a history of chemotherapy within 1 month of the surgery were noted more frequently in the SSI group compared with the non-SSI group (5.6% vs. 0.8%; P < 0.001). In addition, patients with an SSI had a longer median duration of hospital stay (18.5 [14.0-25.0] vs. 10.0 [9.0-13.0] days, P < 0.001). The association between methods of surgery-related variables and SSIs are presented in Table 2. Patients with early gastric cancer were observed more frequently in the non-SSI group (33.8% vs. 49.4%; P = 0.010). Surgery to treat advanced gastric cancer was more common in the SSI group compared with the non-SSI group (62.0% vs. 45.3%; P = 0.005). A higher percentage of patients underwent total gastrectomy (TG) with and without lymph node (LN) dissection in the SSI group than the non-SSI group (26.8% vs. 12.9%; P = 0.001 and 18.3% vs. 10.8%; P = 0.049, respectively).
Univariate analysis of perioperative and postoperative risk factors showed that patients in the SSI group had longer durations of surgery (P < 0.001) compared to the non-SSI group, as well as longer durations of surgical drainage (P = 0.002) (Table 3). Further, the SSI group had a significantly higher percentage of razor use for preoperative hair removal (52.1% vs. 18.2%, P < 0.001) and no surgical drainage was performed in fewer patients in the SSI group than the non-SSI group (9.9% vs. 29.7%, P < 0.001) (Table 3).
Based on our evaluation of operating room environments, SSI risk increased when surgeries were performed in the absence of laminar air-flow (36.6% vs. 7.2%, P < 0.001). There were no significant differences between SSI and non-SSI groups among any other operating rooms factors, including high-efficiency particulate air filters, time for complete air exchange, maintenance of positive pressure, and use of instruments for temperature measurement.
Pathogens associated with SSIs were identified in 56 of 71 patients. A total of 68 microbial species were isolated: 29 Gram-positive, 25 Gram-negative, and 14 other species. The Gram-positive species consisted of methicillin-resistant coagulase negative staphylococci (n = 7), methicillin-resistant Staphylococcus aureus (n = 7), Enterococcus faecalis (n = 7), Enterococcus faecium (n = 4), methicillin-sensitive Staphylococcus aureus (n = 3), and methicillin-sensitive coagulase-negative staphylococci (n = 1). The Gram-negative species consisted of Enterobacter cloacae (n = 11), Klebsiella pneumonia (n = 5), Escherichia coli (n = 4), Acinetobacter baumannii (n = 3), and Pseudomonas aeruginosa (n = 2).
Table 4 shows multivariate adjusted odds ratios for SSIs after gastric surgery. Independent risk factors for SSIs after gastric surgery were prolonged operation time (P = 0.002), use of a razor for preoperative hair-removal (P = 0.010), and absence of laminar flow in the operating room (P = 0.024).

Discussion

We performed a prospective cohort study to identify risk factors for SSI after gastric surgery. We found that prolonged surgery time, use of a razor for preoperative hair removal, and absence of laminar flow in the operating room were independent risk factors for SSI following gastric surgery. Gastrointestinal surgery is relatively common in Korea, especially to treat gastric cancer. The 2007 National Survey in Korea, reported the incidence of gastric cancer in men and women to be 62.8 and 25.7 cases per 100,000 people, respectively [17]. Therefore, the results of this study on SSI incidence in patients undergoing gastric surgery may be especially meaningful.
The rates of SSI for individual procedures vary widely depending on numerous factors, including population, hospital size, surgeon experience, and post-surgery surveillance methods. In addition, nonteaching hospitals generally have lower SSI rates than teaching hospitals [27]. Several studies have noted an increased risk of SSI in patients with cancer who undergo surgical procedures [28]. Previous studies have reported rate and risk factors for SSIs after gastric surgery in Korea. Kim et al. [29] evaluated a total of 499 cases for SSI between July and December 2007 in 5 teaching hospitals with more than 500 beds. They found an SSI rate of 4.4% (22/499), and reported that diabetes mellitus, reoperation, emergent operation, and transfusion were more frequent in the infected group. Likewise, another prospective study monitored 4,238 patients across 20 Korean hospitals between 2007 and 2009 for SSIs for 30 days after gastric surgery [30], and reported an SSI rate of 4.0% (170/4,068) with Staphylococcus aureus and Klebsiella pneumonia as most frequently isolated microorganisms. In addition, male gender, reoperation, combined multiple procedures, prophylactic administration of the first antibiotic dose after skin incision, and prolonged administration (≥7 days) of prophylactic antibiotics were all independently associated with increased risk of SSI. Another study monitored a total of 3,286 cases from 23 hospitals in Korea between July 2010 and June 2011 (1 hospital with < 500 beds, 12 hospitals with 700-899 beds, and 10 hospitals with > 900 beds) [31]. In that study, the SSI rate after gastric surgery was 3.5% (115/3,286), and enterococci (n = 19) was the most frequently detected pathogen. In the present study, we observed an SSI rate of 3.3% (71/2,091); staphylococci (n = 14) and enterococci (n = 11) were most frequently isolated. We observed a lower SSI rate after gastric surgery than that found in previous reports; various methods for monitoring nosocomial infections may have contributed to this improved rate.
In our study, using both univariate and multivariate regression analyses, we confirmed that prolonged operation time is a risk factor for SSI after gastric surgery. Our findings were similar to previously reported NNIS data, which included the 75th percentile of operation duration after initial cut point (3 hours)[32, 33].
We found that preoperative hair removal with a razor was a significant and independent risk factor for SSI after gastric surgery. Shaving with a razor before surgery is a well-documented risk factor for SSI, and guidelines from the CDC Healthcare Infection Control Practices Advisory Committee (HICPAC) recommend avoidance of hair removal before surgery when possible and the use of clippers if hair removal is necessary [2]. Despite these guidelines, we were surprised to find that 19.4% (405/2,091) of study patients were shaved with a razor before gastric surgery. Thus, avoiding razor shaving before surgery is a modifiable intervention to reduce the risk of SSIs.
Laminar airflow ventilation systems in operating rooms are frequently recommended for to prevent SSIs. However, for all other types of surgery, there is no evidence from controlled clinical trials that clean air conditions are beneficial for the prevention of post-surgical infections. HICPAC guidelines for the prevention of SSIs [2], published in 1999, recommended to "consider performing orthopedic implant operations in operating rooms supplied with ultraclean air" which was classified as a category II recommendation. Since then, no further evidence from controlled trials has supported the need for clean air conditions. Consequently, the 2003 HICPAC guidelines for environmental infection control [34] do not recommend recommendation on performing orthopedic implant surgery in rooms supplied with laminar airflow. In 2011, two additional large cohort studies investigated the effects of laminar airflow on SSI rates following orthopedic surgery [35, 36].
Neither study found that SSI rates were lower in patients whose operations were performed under laminar airflow conditions in one study, the opposite was found [35]. On the other hand, some studies have shown that laminar airflow systems reduce bacterial burden in operating room air [37], especially when comparing old and new operating rooms [38]. However, there has been no correlation established between airborne bacteria counts and SSI rates.
In this study, absence of laminar airflow in operating room increased the risk of SSIs by 2.45 fold according to the results of multivariate analysis. Although the benefits of laminar airflow for preventing SSIs is a matter of debate and implementation and continued operation of laminar airflow technology is costly compared with conventional ventilation systems, the results of our study provide strong evidence to support the benefits of laminar airflow in operating rooms.
Perioperative antimicrobial prophylaxis is intended to eliminate most of the pathogens brought into wounds shortly before and/or during surgical procedures and therefore decrease the risk of subsequent SSIs. Gram-positive bacteria should be covered by selected antibiotics for this purpose [39], and timely administration is crucial in order to achieve the highest local concentration of the chosen antibiotic regimen at the beginning time of surgery [40]. However, there were no significant differences between the SSI and non-SSI groups according to optimal antibiotic prophylaxis in our study. Although this lack of benefit from antimicrobial prophylaxis was unexpected, several other studies have reported similar observations [41, 42]. The effectiveness of prophylactic antibiotics varies among types of gastrointestinal surgery. A meta-analysis of laparoscopic cholecystectomies showed that prophylactic antibiotics are ineffective in preventing postsurgical complications, while antibiotic prophylaxis was shown to reduce SSIs in colectomies and appendectomies [26, 43, 44]. In colon surgery, randomized clinical trials to evaluate prophylactic antibiotics were conducted in the 1980s, and placebo groups had SSI rates of approximately 40%, nearly twice the rate of our corresponding group [26]. Although not all of our results are generalizable, improvement of other pre- and intraoperative patient management such as avoiding preoperative shaving and prevention of hypothermia may contribute to reduced risks. In addition, the overall reduction of SSI rates in colectomies may make it difficult to determine the effectiveness of prophylactic antibiotic.
One limitation of this study was that the NNIS was not predictive for SSI occurrence. In addition, we did not evaluate risk factors of SSI in patients with colon surgery; therefore, we could not directly compare differences between risk factors for gastric and colon surgeries.
In conclusion, SSI risk after gastric surgery was mainly associated with prolonged surgeries, use of razors for preoperative hair removal, and absence of laminar flow in operating rooms. These factors are potentially modifiable, and we believe that these results will be helpful in lowering SSI rates after gastric surgery in Korea.

Figures and Tables

Table 1
Baseline characteristics and preoperative status of study patients
ic-45-422-i001

SD, standard deviation; BMI, body mass index; DM, diabetes mellitus; SOT, solid organ transplantation; HS, hospital stay; Hb, hemoglobin; SSI, surgical site infection.

Data are expressed as the mean ± SD, number (percent), or median (interquartile range).

aStudent's t-test.

bMann-Whitney U test.

cFisher's Exact Test.

Table 2
Association between selected variables and surgical site infection following gastric surgery
ic-45-422-i002

GU, gastric ulcer; TG, total gastrectomy; LN, lymph node; PG, partial gastrectomy; DG, distal gastrectomy; STG, subtotal gastrectomy; NS, not significant; SSI, surgical site infection.

aPearson Chi-square.

bGastric surgery due to obesity.

cFisher's Exact Test.

Table 3
Perioperative and postoperative risk factors of surgical site infection
ic-45-422-i003

ASA, American Society of Anesthesiology; NNIS, National Nosocomial Infection Surveillance; OP, operation; HEPA, high-efficiency particulate air; NS, not significant; SD, standard deviation; SSI, surgical site infection.

Data are expressed as the mean ± SD or number (percent) or median (interquartile range).

ahealthy, 1; mild systemic disorder, 2; severe systemic disorder, ≥ 3.

bMann-Whitney U test.

cStudent's t-test.

Table 4
Multivariate analysis of SSI risk factors
ic-45-422-i004

CI, confidence interval; SSI, surgical site infection.

Acknowledgment

This study was supported by a grant of the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea (A102065).

Notes

No conflicts of interest.

References

1. Dellinger EP, Gross PA, Barrett TL, Krause PJ, Martone WJ, McGowan JE Jr, Sweet RL, Wenzel RP. Infectious Diseases Society of America. Quality standard for antimicrobial prophylaxis in surgical procedures. Clin Infect Dis. 1994; 18:422–427.
crossref
2. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Hospital Infection Control Practices Advisory Committee. Guideline for prevention of surgical site infection, 1999. Infect Control Hosp Epidemiol. 1999; 20:250–278. quiz 279-80.
crossref
3. . The Society for Hospital Epidemiology of America. The Association for Practitioners in Infection Control. The Centers for Disease Control. The Surgical Infection Society. Consensus paper on the surveillance of surgical wound infections. Infect Control Hosp Epidemiol. 1992; 13:599–605.
4. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol. 1992; 13:606–608.
crossref
5. Astagneau P, Rioux C, Golliot F, Brücker G. INCISO Network Study Group. Morbidity and mortality associated with surgical site infections: results from the 1997-1999 INCISO surveillance. J Hosp Infect. 2001; 48:267–274.
crossref
6. Ríos J, Murillo C, Carrasco G, Humet C. Increase in costs attributable to surgical infection after appendicectomy and colectomy. Gac Sanit. 2003; 17:218–225.
7. Culver DH, Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG, Banerjee SN, Edwards JR, Tolson JS, Henderson TS, Hughes JM. National Nosocomial Infections Surveillance System. Surgical wound infection rates by wound class, operative procedure, and patient risk index. Am J Med. 1991; 91:152S–157S.
crossref
8. Gaynes RP, Culver DH, Horan TC, Edwards JR, Richards C, Tolson JS. Surgical site infection (SSI) rates in the United States, 1992-1998: the National Nosocomial Infections Surveillance System basic SSI risk index. Clin Infect Dis. 2001; 33:Suppl 2. S69–S77.
crossref
9. Roy MC, Herwaldt LA, Embrey R, Kuhns K, Wenzel RP, Perl TM. Does the Centers for Disease Control's NNIS system risk index stratify patients undergoing cardiothoracic operations by their risk of surgical-site infection? Infect Control Hosp Epidemiol. 2000; 21:186–190.
crossref
10. Lee HH, Shim KN, Kwon JM, Jung SA, Yoo K. Complications of percutaneous endoscopic gastrostomy and risk factors of peristomal wound infection. Korean J Med. 2004; 67:15–21.
11. Ahn YJ, Sohng KY. Factors related to surgical site infections in patients undergoing general surgery. J Korean Acad Fundam Nurs. 2005; 12:113–120.
12. Lee S, Kim S, Lee J, Lee K. Risk factors for surgical site infection among patients in a general hospital. Korean J Nosocomial Infect Control. 2007; 12:9–20.
13. Sakong P, Lee JS, Lee EJ, Ko KP, Kim CH, Kim Y, Kim YI. Association between the pattern of prophylactic antibiotic use and surgical site infection rate for major surgeries in Korea. J Prev Med Public Health. 2009; 42:12–20.
crossref
14. Tang R, Chen HH, Wang YL, Changchien CR, Chen JS, Hsu KC, Chiang JM, Wang JY. Risk factors for surgical site infection after elective resection of the colon and rectum: a single-center prospective study of 2,809 consecutive patients. Ann Surg. 2001; 234:181–189.
crossref
15. Hedrick TL, Heckman JA, Smith RL, Sawyer RG, Friel CM, Foley EF. Efficacy of protocol implementation on incidence of wound infection in colorectal operations. J Am Coll Surg. 2007; 205:432–438.
crossref
16. Imai E, Ueda M, Kanao K, Kubota T, Hasegawa H, Omae K, Kitajima M. Surgical site infection risk factors identified by multivariate analysis for patient undergoing laparoscopic, open colon, and gastric surgery. Am J Infect Control. 2008; 36:727–731.
crossref
17. National Cancer Information Center. Yearly report of Korea on cancer development (2007.1.1-2007.12.31). Ministry of Health and Welfare for the Korean Government. Goyang: NCC;2010.
18. Imai E, Ueda M, Kanao K, Miyaki K, Kubota T, Kitajima M. Surgical site infection surveillance after open gastrectomy and risk factors for surgical site infection. J Infect Chemother. 2005; 11:141–145.
crossref
19. Haley RW, Culver DH, Morgan WM, White JW, Emori TG, Hooton TM. Identifying patients at high risk of surgical wound infection. A simple multivariate index of patient susceptibility and wound contamination. Am J Epidemiol. 1985; 121:206–215.
20. Kluytmans J, Voss A. Prevention of postsurgical infections: some like it hot. Curr Opin Infect Dis. 2002; 15:427–432.
crossref
21. Kaye KS, Schmit K, Pieper C, Sloane R, Caughlan KF, Sexton DJ, Schmader KE. The effect of increasing age on the risk of surgical site infection. J Infect Dis. 2005; 191:1056–1062.
crossref
22. Owens WD, Felts JA, Spitznagel EL Jr. ASA physical status classifications: a study of consistency of ratings. Anesthesiology. 1978; 49:239–243.
23. Horan TC, Emori TG. Definitions of key terms used in the NNIS System. Am J Infect Control. 1997; 25:112–116.
crossref
24. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008; 36:309–332.
crossref
25. Garner JS. CDC guideline for prevention of surgical wound infections, 1985. Supersedes guideline for prevention of surgical wound infections published in 1982. (Originally published in November 1985). Revised. Infect Control. 1986; 7:193–200.
26. Bratzler DW, Houck PM. Surgical Infection Prevention Guidelines Writers Workgroup. American Academy of Orthopaedic Surgeons. American Association of Critical Care Nurses. American Association of Nurse Anesthetists. American College of Surgeons. American College of Osteopathic Surgeons. American Geriatrics Society. American Society of Anesthesiologists. American Society of Colon and Rectal Surgeons. American Society of Health-System Pharmacists. American Society of PeriAnesthesia Nurses. Ascension Health. Association of periOperative Registered Nurses. Association for Professionals in Infection Control and Epidemiology. Infectious Diseases Society of America. Medical Letter. Premier. Society for Healthcare Epidemiology of America. Society of Thoracic Surgeons. Surgical Infection Society. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis. 2004; 38:1706–1715.
crossref
27. Hughes JM, Culver DH, White JW, Jarvis WR, Morgan WM, Munn VP, Mosser JL, Emori TG. Nosocomial infection surveillance, 1980-1982. MMWR CDC Surveill Summ. 1983; 32:1SS–16SS.
28. Guinan JL, McGuckin M, Nowell PC. Management of health-care--associated infections in the oncology patient. Oncology (Williston Park). 2003; 17:415–420. discussion 423-6.
29. Kim ES, Chang YJ, Park YS, Kang JH, Park SY, Kim JY, Lee SE, Kim SH, Kwon SH, Choi YH, Jin HY, Kim HY, Uh Y, Kim BH, Son HJ, Choi HJ. Multicenter surgical site infections surveillance system report, 2007: in total hip and total knee arthroplasties and gastrectomies. Korean J Nosocomial Infect Control. 2008; 13:32–41.
30. Kim ES, Kim HB, Song KH, Kim YK, Kim HH, Jin HY, Jeong SY, Sung J, Cho YK, Lee YS, Oh HB, Kim EC, Kim JM, Choi TY, Choi HJ, Kim HY. Korean Nosocomial Infections Surveillance System (KONIS). Prospective nationwide surveillance of surgical site infections after gastric surgery and risk factor analysis in the Korean Nosocomial Infections Surveillance System (KONIS). Infect Control Hosp Epidemiol. 2012; 33:572–580.
crossref
31. Kim YK, Kim HY, Kim ES, Kim HB, Jin HY, Lee JY, Sung J, Uh Y, Cho YK, Lee YS, Kim EC, Woo JH. Korean surgical site infection surveillance system report: data summary from July 2010 through June 2011. Korean J Nosocomial Infect Control. 2012; 17:1–12.
32. NNIS System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003. Am J Infect Control. 2003; 31:481–498.
33. . National Nosocomial Infections Surveillance (NNIS) report, data summary from October 1986-April 1996, issued May 1996. A report from the National Nosocomial Infections Surveillance (NNIS) System. Am J Infect Control. 1996; 24:380–388.
34. Sehulster L, Chinn RY. CDC. HICPAC. Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep. 2003; 52:1–42.
35. Hooper GJ, Rothwell AG, Frampton C, Wyatt MC. Does the use of laminar flow and space suits reduce early deep infection after total hip and knee replacement?: the ten-year results of the New Zealand Joint Registry. J Bone Joint Surg Br. 2011; 93:85–90.
36. Breier A, Brandt C, Sohr D, Geffers C, Gastmeier P. Laminar airflow ceiling size: no impact on infection rates following hip and knee prosthesis. Infect Control Hosp Epidemiol. 2011; 32:1097–1102.
crossref
37. Whyte W, Hodgson R, Tinkler J. The importance of airborne bacterial contamination of wounds. J Hosp Infect. 1982; 3:123–135.
crossref
38. van Griethuysen AJ, Spies-van Rooijen NH, Hoogenboom-Verdegaal AM. Surveillance of wound infections and a new theatre: unexpected lack of improvement. J Hosp Infect. 1996; 34:99–106.
crossref
39. Wilson MA. Skin and soft-tissue infections: impact of resistant gram-positive bacteria. Am J Surg. 2003; 186:35S–41S. discussion 42S-43S, 61S-64S.
crossref
40. Classen DC, Evans RS, Pestotnik SL, Horn SD, Menlove RL, Burke JP. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med. 1992; 326:281–286.
crossref
41. Walz JM, Paterson CA, Seligowski JM, Heard SO. Surgical site infection following bowel surgery: a retrospective analysis of 1446 patients. Arch Surg. 2006; 141:1014–1018. discussion 1018.
42. Romy S, Eisenring M, Bettschart V, Petignat C, Francioli P, Troillet N. Laparoscope use and surgical site infections in digestive surgery. Ann Surg. 2008; 247:627–632.
crossref
43. Choudhary A, Bechtold ML, Puli SR, Othman MO, Roy PK. Role of prophylactic antibiotics in laparoscopic cholecystectomy: a meta-analysis. J Gastrointest Surg. 2008; 12:1847–1853. discussion 1853.
crossref
44. Andersen BR, Kallehave FL, Andersen HK. Antibiotics versus placebo for prevention of postoperative infection after appendicectomy. Cochrane Database Syst Rev. 2005; CD001439.
crossref
TOOLS
ORCID iDs

Joon-Sup Yeom
https://orcid.org/http://orcid.org/0000-0001-8940-7170

Young-Keun Kim
https://orcid.org/http://orcid.org/0000-0002-2120-6265

Similar articles